1. Home
  2. COCP vs QCLS Comparison

COCP vs QCLS Comparison

Compare COCP & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • QCLS
  • Stock Information
  • Founded
  • COCP 2006
  • QCLS 2014
  • Country
  • COCP United States
  • QCLS United States
  • Employees
  • COCP N/A
  • QCLS N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • QCLS Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • COCP Health Care
  • QCLS Health Care
  • Exchange
  • COCP Nasdaq
  • QCLS Nasdaq
  • Market Cap
  • COCP 15.4M
  • QCLS 12.5M
  • IPO Year
  • COCP N/A
  • QCLS N/A
  • Fundamental
  • Price
  • COCP $1.07
  • QCLS $2.95
  • Analyst Decision
  • COCP Strong Buy
  • QCLS
  • Analyst Count
  • COCP 1
  • QCLS 0
  • Target Price
  • COCP $6.00
  • QCLS N/A
  • AVG Volume (30 Days)
  • COCP 197.1K
  • QCLS 1.2M
  • Earning Date
  • COCP 11-14-2025
  • QCLS 11-12-2025
  • Dividend Yield
  • COCP N/A
  • QCLS N/A
  • EPS Growth
  • COCP N/A
  • QCLS N/A
  • EPS
  • COCP N/A
  • QCLS N/A
  • Revenue
  • COCP N/A
  • QCLS N/A
  • Revenue This Year
  • COCP N/A
  • QCLS N/A
  • Revenue Next Year
  • COCP N/A
  • QCLS N/A
  • P/E Ratio
  • COCP N/A
  • QCLS N/A
  • Revenue Growth
  • COCP N/A
  • QCLS N/A
  • 52 Week Low
  • COCP $1.00
  • QCLS $2.55
  • 52 Week High
  • COCP $3.26
  • QCLS $164.00
  • Technical
  • Relative Strength Index (RSI)
  • COCP 43.45
  • QCLS N/A
  • Support Level
  • COCP $1.06
  • QCLS N/A
  • Resistance Level
  • COCP $1.15
  • QCLS N/A
  • Average True Range (ATR)
  • COCP 0.07
  • QCLS 0.00
  • MACD
  • COCP 0.01
  • QCLS 0.00
  • Stochastic Oscillator
  • COCP 23.54
  • QCLS 0.00

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About QCLS Q/C Technologies Inc. Common Stock

Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Share on Social Networks: